| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 75, 1535-1539, Copyright © 1992 by Endocrine Society
ARTICLES |
M Mori, M Yamada, T Satoh, M Murakami, T Iriuchijima and I Kobayashi
First Department of Medicine, Gunma University, School of Medicine, Maebashi, Japan.
We scrutinized the possible existence of human prepro-THR messenger RNA (mRNA) and of its posttranslational processing products in the human placenta. Human placental mRNA of preproTRH was found to have a single species identical to that predicted from the hypothalamic mRNA, and could be reverse transcribed to complementary DNA (cDNA) encoding preproTRH in a size similar to the hypothalamic counterpart by means of reverse-transcriptase-polymerase chain reaction. Five different intervening peptides, designated human TRH-associated peptide (hTAP) [hTAP-1, preproTRH(90-111); hTAP-2, preproTRH(120-132); hTAP-3, preproTRH(141-149); hTAP-4, preproTRH(158-183); hTAP-5, preproTRH(192- 224)], and a TRH precursor comprising the TRH progenitor sequence (octa- TRH) were synthesized, and six different antisera raised against individual peptides were used to develop specific RIA systems. Significant concentrations of hTAP-5 and octa-TRH-like immunoreactivities were quantitated in acid extracts of human placentae. In human hypothalamic extracts, immunoreactivities of hTAP- 3, hTAP-4, hTAP-5, and octa-TRH, were apparently detected. Chromotographic analysis showed a single peak corresponding to each authentic peptide in RIA systems of hTAPs detected. In placentae, a single peak of octa-TRH-like substance was observed, and two octa-TRH- like substances with different molecular weights detected in hypothalami. The present data indicate that unique posttranslational processing steps of human preproTRH differ in human placentae and hypothalami, and that the human tissues involve profound amounts of several preproTRH-related peptides which do not comprise the TRH progenitor sequence.
This article has been cited by other articles:
![]() |
J. Ehrchen, A. Peters, D. K. Lüdecke, T. Visser, and K. Bauer Analysis of Thyrotropin-Releasing Hormone-Signaling Components in Pituitary Adenomas of Patients with Acromegaly J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2709 - 2713. [Abstract] [Full Text] |
||||
![]() |
N. Shibusawa, M. Yamada, J. Hirato Tuyoshi Monden, T. Satoh, and M. Mori Requirement of Thyrotropin-Releasing Hormone for the Postnatal Functions of Pituitary Thyrotrophs: Ontogeny Study of Congenital Tertiary Hypothyroidism in Mice Mol. Endocrinol., January 1, 2000; 14(1): 137 - 146. [Abstract] [Full Text] |
||||
![]() |
E. A. Nillni and K. A. Sevarino The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides Endocr. Rev., October 1, 1999; 20(5): 599 - 648. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |